Navigation Links
MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
Date:6/17/2008

MonoSol Rx to initiate pivotal trials for ondansetron thin film immediately

WARREN, N.J. and PORTAGE, Ind., June 17 /PRNewswire/ -- MonoSol Rx, a drug delivery company specializing in dissolving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), announced today that they have entered into an exclusive licensing agreement under which Strativa has acquired the U.S. commercialization rights to the thin film formulation of ondansetron from MonoSol Rx. The ondansetron thin film formulation is a new oral formulation in development for the prevention of chemotherapy-induced nausea and vomiting, prevention of nausea and vomiting associated with radiotherapy, and post-operative nausea and vomiting.

Based on the results of a recently completed pilot bio-equivalency study, MonoSol Rx is initiating pivotal trials immediately to enable application for drug approval in the U.S. Subject to favorable results, it is anticipated that Strativa could file an NDA with the appropriate regulatory authorities within the next twelve months.

Under terms of the agreement, MonoSol Rx will receive milestone payments prior to commercial launch and sales-based milestones that could total $23.5 million as well as payments for purchase of product supply and royalties on net sales.

Anti-emetic therapies constitute one of the largest segments of the supportive care market in the U.S., with annual sales of over $1.6 billion in 2007. Ondansetron was the prescription leader in the category in 2007, with 2.7 million scripts written.

A. Mark Schobel, president and CEO of MonoSol Rx, stated, "We are very excited about the collaboration with Strativa. They are uniquely positioned to market and sell our ondansetron thin film product given their focus on marketing novel prescription drugs. Thin film is particularly well suited for this indication
'/>"/>

SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations
2. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
3. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
4. KineMed Licenses GeneGos MetaCore
5. Xceed Molecular Licenses Signature from Moffitt Cancer Center and Adds Moffitt to Strategic Collaborator Program
6. Nuvo licenses topical pain product from Paladin
7. ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
8. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
9. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
10. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
11. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Andrew Hawley of Vintage Rock Posters ... concert posters. The Who and the Doors played together at ... 1968. According to Hawley, “The Who toured the United States ... college campuses. Perhaps the most famous Who poster was a ... the Doors on August 2, 1968 at the Singer Bowl ...
(Date:3/28/2015)... 28, 2015 The "Petrick Sustainable ... sustainable health. After 18 years of research and experience ... UFC contenders, Dr. Jon Petrick is excited to be ... some of the immediate benefits of this radical new ... levels of strength of the immune system, faster healing ...
(Date:3/28/2015)... 28, 2015 Servpro of Paso ... week released a report about the link between mold ... sufferers, and according to recent medical research, may even ... to the Environmental Protection Agency, people with sensitivity to ... in mold may trigger asthma attacks for asthma sufferers. ...
(Date:3/27/2015)... Red Deer, Alberta (PRWEB) March 27, 2015 ... had, until then, prevented her from working, Monica K. arrived ... day in the mending department quiet, defensive and scared. The ... Employment Placement & Support Services (EPSS) to offer jobs ... it does take patience and a willingness to begin with ...
(Date:3/27/2015)... Mo (PRWEB) March 27, 2015 ... for patients undergoing percutaneous coronary intervention (PCI), resulting ... have observed a “risk-treatment paradox,” in which the ... from treatment are treated less often with bleeding ... at Saint Luke’s Mid America Heart Institute asked ...
Breaking Medicine News(10 mins):Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 2Health News:Precision Medicine Improves Use of Bleeding Avoidance Strategies and Reduces Bleeding in Patients Undergoing Percutaneous Coronary Intervention 3
... quite common for a female song sparrow to stray from ... but a new study shows that sleeping around can be ... American Naturalist, found that offspring conceived outside sparrows, ... within-pair offspring. The findings throw a monkey wrench into theories ...
... of Environmental Health Sciences (NIEHS), part of the National ... Research Program (SRP) at the University of California, San ... grant will fund continued research on the molecular and ... and other hazardous waste sites. It is the ...
... By Maureen Salamon HealthDay Reporter , ... anticipated move sure to unleash heated debate, a prominent ... all ages no longer be screened for prostate cancer ... The U.S. Preventive Services Task Force, an independent group ...
... , TUESDAY, May 22 (HealthDay News) -- ... C virus could develop potentially life-threatening liver complications over ... Researchers evaluated medical insurance claims data and found ... liver disease in 2008, and estimated that another 300,000 ...
... When thousands of psychiatrists attend their field,s largest annual ... into drug treatments report overwhelmingly on positive results. ... in the Journal of Clinical Psychopharmacology by ... Yale University, who analyzed the presentations given at two ...
... The Food and Drug Administration has approved a new ... disorders. The test, or assay, was developed by an expert ... Lawrence Schwartz, M.D., Ph.D., chair of the Division of ... Professor of Medicine at VCU, has spent more than 30 ...
Cached Medicine News:Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 2Health News:Bias found in mental health drug research presented at major psychiatric meeting 3Health News:FDA clears test developed in partnership with VCU researcher 2
(Date:3/27/2015)... DIEGO , March 27, 2015   ... company, today announced new data showing that, compared ... TM technology provided highly equivalent interpretations of ... disease, and did so in a fraction of ... the way for more comprehensive genetic analysis in ...
(Date:3/27/2015)... 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... for trauma patients. Available in both small ... External Fixation System from Zimmer is a modular system ...   The XtraFix System allows surgeons to eliminate ... fixation process, resulting in saved time, costs and overall team ...
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
Breaking Medicine Technology:New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... 3, 2007 - Xanthus,Pharmaceuticals, Inc today presented ... pathological signs of chronic,disease in an animal ... by Stephen J. Karlik, Ph.D., Professor of ... London, Ontario,together with researchers from Xanthus in ...
... Announces Positive Data in Nonclinical (IND) In- ... May 3, 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceuticals ... pleased to announce positive results were attained ... well recognized in-vitro models. , Although nonclinical ...
Cached Medicine Technology:Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
... ARK-760A is an Auto Refractor/Keratometer ... subjective refinement. Electronic elevation, automatic ... unequalled accuracy and all the ... the Marco Automatic Refractors/Keratometer famous, ...
Sterile perfluorocarbon for intraocular Application....
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: